While FAS is expressed in Tregs from healthy individuals and cancer patients, elevated FAS-L is seen only in Tregs from cancer patients, linked to poor CD8+ T-cell infiltration and FOXP3+ Treg predominance [99]. Here, CD8A is linked to cancer.